Be Clinical, an Indian skincare startup that’s all about science-backed stuff for aging skin, just got ₹6 crore in seed funding. V3 Ventures (started by Arjun Vaidya) led the round, and Titan Capital (backed by Kunal Bahl and Rohit Bansal) also chipped in, showing they really believe in the brand.
Hemangi Dhir started Be Clinical in May 2025 because she saw a hole in the Indian skincare scene. There weren’t many real, science-based products made for Indian skin and conditions. Most stuff out there is just based on trends or super expensive treatments at clinics. Be Clinical wants to be a D2C brand that puts the product first, using testing and its own research and manufacturing. It seems like this approach is working because Indian shoppers are getting smarter, reading ingredient lists, and wanting products that actually do something.
Even though they’re pretty new, Be Clinical is doing well. By the end of 2025, they had over 25,000 customers, which shows that people are catching on and start to trust their India-specific products. This early success says the company and its products fills a gap in the market.
The money they just raised will go to a few things. They’ll put a bunch into research so they can come up with even better products. They also want to improve their factory with new machines to make more products. Some of that fund will go for packaging to make them protected and looking good that keeps working well.
Hemangi Dhir said that she’s grateful for the support. She is promising to keeps the company to a place where it will be honest, do testing, and talk openly about aging.
Investors think Be Clinical is in a good spot because people want skincare that’s proven to work, they’re willing to spend money for anti-aging earlier. Also, they’re moving toward less products that are effective. The people backing the company like that the founder has a clear idea, knows a lot about products, and makes everything themselves.
As Be Clinical grows, they want to be known as the go-to brand for real, scientific skincare in India’s growing D2C world. This funding round is showing that people are still excited about brands that focus on good products and building trust.
